Viewing StudyNCT00486460

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00486460
Status: UNKNOWN
Last Update Posted: 2007-06-14
First Post: 2007-06-13
Brief Title: Phase III Trial of Gemcitabine Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor: Tel-Aviv Sourasky Medical Center
Organization: Tel-Aviv Sourasky Medical Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
Inoperatable View
Locally advanced or metastatic adenocarcinoma of the View
pancreas View
confirmed by histology or cytology View